MannKind Corporation investor relations material

Listen to the latest call from MannKind Corporation

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. The company offers Afrezza (insulin human), a small molecule inhalation powder that delivers rapid insulin absorption directly into the bloodstream. Its product portfolio also includes Technosphere dry powder inhalation system and pulmonary delivery devices.

Dig deeper into the MannKind Corporation fundamentals on Quartr.